Zimmer ContiCure

Pelvic floor therapy, delivered fully clothed.

What it treats

Applications

  • Stress, mixed and urge urinary incontinence in women.
  • Postnatal pelvic floor recovery. Zimmer's own term for this is "body-after-baby treatment": strengthening of the pelvic floor musculature.
  • Post-prostatectomy incontinence in men.
The mechanism

How it works

ContiCure treats through a pulsed inductive electromagnetic field, at around 1.5 Tesla. The field depolarises the motor neurons under the pelvic floor and makes the muscle contract directly, without a probe and without an exercise the patient has to get right on their own. The result is deep pelvic floor stimulation and neuromuscular restoration, delivered while the patient sits, dressed, in the chair.

Session length

20 to 30 minutes

Clothing

None removed

Downtime

None

Course, per Zimmer

8 to 10 treatments

In the room

Why this system

Fully clothed, adjustable position

ContiCure treats through the chair, not a probe. Three interchangeable inlays adjust the patient's position, so no clothing comes off.

Treats both sexes

Stress, mixed and urge incontinence in women, postnatal pelvic floor recovery, and post-prostatectomy incontinence in men, from one console.

Backed by a named clinical study

A prospective study run with CIMEG Madrid followed 42 patients for eight weeks, with a three-month follow-up.

Five preset protocols

Stress, Urge, Mixed, Keep U in Shape and a demo programme, each with a fixed frequency and a fixed duration, dialled in before the patient sits down.

One chair. One room. Two patient populations.

  • ContiCure shares its chair, article 3211, with ZTone. Two treatment paths, one piece of furniture in the room.
  • Five preset protocols cover the range of incontinence presentations Zimmer documents for the device.
  • Keep U in Shape is Zimmer's own postnatal-focused programme.
  • ContiCure ships with three different inlays to adjust the treatment position.
The detail

What to know

Preset protocols

  • Stress Incontinence: Up to 60 Hz, 22 minutes
  • Urge Incontinence: Low frequencies up to 5 Hz, 31 minutes
  • Mixed Incontinence: 60 Hz and low frequencies up to 5 Hz, 29 minutes
  • Keep U in Shape: 40, 50 and 60 Hz, 21 minutes
  • Mixed Level 2 (demo): F1: 50 Hz (3s on, 6s off); F2: 30 Hz, 25 minutes

Clinical evidence (5)

A prospective study of ContiCure was run at CIMEG Madrid with Zimmer MedizinSysteme.

  • Authors: Dr. Ernesto Delgado Cidranes, Dra. Zuramis Estrada Blanco, Physio Sandra Rodriguez Garcia and Physio Carlos Lopez Moreno. 42 patients, eight weeks of treatment, follow-up at three months: stress 43%, mixed 28%, urge 24%, other 5%.
  • Satisfactory outcome in 97% of patients, improvement maintained in more than 90% at three months, elastographic changes and improved muscle tone in 95.2%, satisfaction 64% highly satisfied, 33% satisfied, 3% not satisfied.
  • Results: no adverse reactions, no muscle injuries, and all patients completed treatment. Five patients reported increased pain after the first session, VAS above 5, lasting over three hours.
  • The study's conclusion: "ContiCure is safe, well tolerated and effective for the treatment of mild and moderate urinary incontinence."
  • The white paper covers urinary incontinence only. It carries no claim about sexual function, and none is made for ContiCure on this page.

Contraindications (16)

ContiCure should not be used in the presence of any of the following, as published by Zimmer:

  • Fever
  • Application over a menstruating uterus
  • Application over areas of skin lacking normal sensation
  • Metal or electronic implants in the treatment area
  • Implanted defibrillators
  • Implanted neurostimulators
  • Drug pumps
  • Malignant tumour
  • Haemorrhagic conditions
  • Epilepsy
  • Recent surgical procedure
  • Pulmonary insufficiency
  • Pregnancy
  • Cardiac pacemakers
  • Application in the area of a growth plate
  • Application in the head area

New approach: Gentle Pro plus ContiCure

Zimmer's own Gentle Pro training material, presented by Dr. med. Bernhard Schoensee, a urologist in Berlin, and Michaela Wolf, Head of Zimmer Academy, pairs the two devices for the ED patient who also needs pelvic floor work: Gentle Pro treats the erectile dysfunction, ContiCure trains the pelvic floor, in the same course of care.

This is a Zimmer-documented combination, not the ZTone upgrade below. ZTone plus ContiCure is a separate, body-toning and incontinence hardware path.

Already own ZTone?

Clinics already running ZTone for body toning do not need a second chair for incontinence work. ZTone's incontinence upgrade kit adds an applicator and the chair, article 3211, the same chair ContiCure uses.

This is a routing question, not a comparison. ZTone's upgrade carries none of ContiCure's clinical documentation: the CIMEG white paper and Zimmer's incontinence protocols belong to ContiCure.

Does the patient need to undress for ContiCure?

No. ContiCure is delivered fully clothed, using interchangeable inlays to adjust the patient's position in the chair.

How long does a session take, and how many are needed?

20 to 30 minutes per session, no clothing removed, no downtime. Zimmer recommends a course of 8 to 10 treatments.

Does ContiCure treat sexual function?

No. The ContiCure white paper covers urinary incontinence only and makes no claim about sexual function. Zimmer's documented sexual-function protocols sit with Gentle Pro, not ContiCure.

Is ContiCure indicated for men?

Yes. Zimmer recommends it for post-prostatectomy incontinence, alongside stress, mixed and urge incontinence in women.

Do ZTone and ContiCure use the same equipment?

They share one chair, article 3211. A clinic running ZTone can add ContiCure's pelvic floor therapy through the incontinence upgrade kit, without a second chair.

DNA Nexus support

DNA Nexus will handle installation and set up the chair and console on site. Staff training covers the five preset protocols and Zimmer's application recommendations, so a session starts correctly from day one. After-sales technical support runs from Cairo, alongside the rest of the DNA Nexus Zimmer portfolio.

Zimmer ContiCure